Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Current status and future directions for the diagnosis and management of mild cognitive impairment in Southeast Asia: A SEACURE consensus paper 2025-03-12
  2. Digital biomarkers and sex impacts in Alzheimer's disease management - potential utility for innovative 3P medicine approach 2022-06-06
  3. EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia 2012-09-01

Studies

3 studies carry this tag.

Date range

2012 to 2025

Top journals

  • European journal of neurology 1
  • The EPMA journal 1
  • The journal of prevention of Alzheimer's disease 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Current status and future directions for the diagnosis and management of mild cognitive impairment in Southeast Asia: A SEACURE consensus paper

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. The journal of prevention of Alzheimer's disease 2025-03-12 Biomarkers

    Global aging populations are facing increased prevalence of mild cognitive impairment (MCI) - the preclinical stage of dementia characterized by single/multi-domain neurocognitive decline that does not impair an individual's normal daily functioning.

  2. Digital biomarkers and sex impacts in Alzheimer's disease management - potential utility for innovative 3P medicine approach

    ✓ Peer-reviewed alzhub usefulness score 67 out of 100. The EPMA journal 2022-06-06 Cognitive tests and assessment

    Digital biomarkers are defined as objective, quantifiable physiological and behavioral data that are collected and measured by means of digital devices.

  3. EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia

    ✓ Peer-reviewed alzhub usefulness score 64 out of 100. European journal of neurology 2012-09-01 Tau biomarkers

    The last version of the EFNS dementia guidelines is from 2007.

All topic tags with their study counts